Mikhailova, E.; Illarionova, O.; Komkov, A.; Zerkalenkova, E.; Mamedov, I.; Shelikhova, L.; Olshanskaya, Y.; Miakova, N.; Novichkova, G.; Karachunskiy, A.;
et al. Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. Cancers 2022, 14, 5445.
https://doi.org/10.3390/cancers14215445
AMA Style
Mikhailova E, Illarionova O, Komkov A, Zerkalenkova E, Mamedov I, Shelikhova L, Olshanskaya Y, Miakova N, Novichkova G, Karachunskiy A,
et al. Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. Cancers. 2022; 14(21):5445.
https://doi.org/10.3390/cancers14215445
Chicago/Turabian Style
Mikhailova, Ekaterina, Olga Illarionova, Alexander Komkov, Elena Zerkalenkova, Ilgar Mamedov, Larisa Shelikhova, Yulia Olshanskaya, Natalia Miakova, Galina Novichkova, Alexander Karachunskiy,
and et al. 2022. "Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy" Cancers 14, no. 21: 5445.
https://doi.org/10.3390/cancers14215445
APA Style
Mikhailova, E., Illarionova, O., Komkov, A., Zerkalenkova, E., Mamedov, I., Shelikhova, L., Olshanskaya, Y., Miakova, N., Novichkova, G., Karachunskiy, A., Maschan, M., & Popov, A.
(2022). Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. Cancers, 14(21), 5445.
https://doi.org/10.3390/cancers14215445
